|
Volumn 49, Issue APR., 2003, Pages 489-491
|
Clinical guidelines for depressive disorders: Summary of recommendations relevant to family physicians
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMFEBUTAMONE;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
CITALOPRAM;
CLOMIPRAMINE;
FLUOXETINE;
FLUVOXAMINE;
MAPROTILINE;
MIRTAZAPINE;
MOCLOBEMIDE;
MONOAMINE OXIDASE INHIBITOR;
NEFAZODONE;
NORTRIPTYLINE;
PAROXETINE;
PHENELZINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRAZODONE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ANTICHOLINERGIC EFFECT;
ARTICLE;
BEHAVIOR THERAPY;
CARDIOVASCULAR DISEASE;
CLINICAL FEATURE;
CLINICAL TRIAL;
COGNITIVE THERAPY;
DISEASE CLASSIFICATION;
DRUG INDICATION;
EVIDENCE BASED MEDICINE;
GENERAL PRACTICE;
HUMAN;
INTERNET;
INTERPERSONAL COMMUNICATION;
MAJOR DEPRESSION;
PRACTICE GUIDELINE;
PREVALENCE;
PRIMARY MEDICAL CARE;
PROBLEM SOLVING;
PSYCHOTHERAPY;
SEXUAL DYSFUNCTION;
CANADA;
DEPRESSION;
DIFFERENTIAL DIAGNOSIS;
FEMALE;
MALE;
ANTIDEPRESSIVE AGENTS;
CANADA;
DEPRESSIVE DISORDER;
DIAGNOSIS, DIFFERENTIAL;
FAMILY PRACTICE;
FEMALE;
HUMANS;
MALE;
PRACTICE GUIDELINES;
PSYCHOTHERAPY;
|
EID: 0038052233
PISSN: 0008350X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (16)
|
References (5)
|